Cerebrotendinous Xanthomatoses
Oncology·MeSH: Fructose-1,6-Diphosphatase Deficiency
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Cerebrotendinous Xanthomatoses?
There are 2 clinical trials targeting Cerebrotendinous Xanthomatoses tracked by BioSniper.
What is the prevalence of Cerebrotendinous Xanthomatoses?
The estimated prevalence of Cerebrotendinous Xanthomatoses is approximately 5.0 per 100,000 population.
Deep-dive into Cerebrotendinous Xanthomatoses
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis